Literature DB >> 25135718

Effect of TRPV1 channel on proliferation and apoptosis of airway smooth muscle cells of rats.

Li-Min Zhao1, Hong-Yan Kuang1, Luo-Xian Zhang1, Ji-Zhen Wu1, Xian-Liang Chen1, Xiao-Yu Zhang1, Li-Jun Ma2.   

Abstract

Airway remodeling is an important pathological feature of asthma and the basis of severe asthma. Proliferation of airway smooth muscle cells (ASMCs) is a major contributor to airway remodeling. As an important Ca(2+) channel, transient receptor potential vanilloid 1 (TRPV1) plays the key role in the cell pathological and physiological processes. This study investigated the expression and activity of TRPV1 channel, and further clarified the effect of TRPV1 channel on the ASMCs proliferation and apoptosis in order to provide the scientific basis to treat asthmatic airway remodeling in clinical practice. Immunofluorescence staining and reverse transcription polymerase chain reaction (RT-PCR) were used to detect the expression of TRPV1 in rat ASMCs. Intracellular Ca(2+) was detected using the single cell confocal fluorescence microscopy measurement loaded with Fluo-4/AM. The cell cycles were observed by flow cytometry. MTT assay and Hoechst 33258 staining were used to detect the proliferation and apoptosis of ASMCs in rats respectively. The data showed that: (1) TRPV1 channel was present in rat ASMCs. (2) TRPV1 channel agonist, capsaicin, increased the Ca(2+) influx in a concentration-dependent manner (EC50=284.3±58 nmol/L). TRPV1 channel antagonist, capsazepine, inhibited Ca(2+) influx in rat ASMCs. (3) Capsaicin significantly increased the percentage of S+G2M ASMCs and the absorbance of MTT assay. Capsazepine had the opposite effect. (4) Capsaicin significantly inhibited the apoptosis, whereas capsazepine had the opposite effect. These results suggest that TRPV1 is present and mediates Ca(2+) influx in rat ASMCs. TRPV1 activity stimulates proliferation of ASMCs in rats.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25135718     DOI: 10.1007/s11596-014-1306-0

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  26 in total

1.  Optical recording reveals novel properties of GSK1016790A-induced vanilloid transient receptor potential channel TRPV4 activity in primary human endothelial cells.

Authors:  Michelle N Sullivan; Michael Francis; Natalie L Pitts; Mark S Taylor; Scott Earley
Journal:  Mol Pharmacol       Date:  2012-06-11       Impact factor: 4.436

2.  Expression and characterization of the intracellular vanilloid receptor (TRPV1) in bronchi from patients with chronic cough.

Authors:  Jennifer E Mitchell; Anne P Campbell; Norman E New; Laura R Sadofsky; Jack A Kastelik; Siobhan A Mulrennan; Steven J Compton; Alyn H Morice
Journal:  Exp Lung Res       Date:  2005-04       Impact factor: 2.459

Review 3.  Treating asthma means treating airway smooth muscle cells.

Authors:  S Zuyderduyn; M B Sukkar; A Fust; S Dhaliwal; J K Burgess
Journal:  Eur Respir J       Date:  2008-08       Impact factor: 16.671

Review 4.  Remodeling in asthma.

Authors:  Saleh Al-Muhsen; Jill R Johnson; Qutayba Hamid
Journal:  J Allergy Clin Immunol       Date:  2011-06-02       Impact factor: 10.793

5.  TRP channels: from understanding to action.

Authors:  Viktorie Vlachova
Journal:  Curr Pharm Biotechnol       Date:  2011-01-01       Impact factor: 2.837

6.  TRPV1-antagonist AMG9810 promotes mouse skin tumorigenesis through EGFR/Akt signaling.

Authors:  Shengqing Li; Ann M Bode; Feng Zhu; Kangdong Liu; Jishuai Zhang; Myoung Ok Kim; Kanamata Reddy; Tatyana Zykova; Wei-ya Ma; Andria L Carper; Alyssa K Langfald; Zigang Dong
Journal:  Carcinogenesis       Date:  2011-02-23       Impact factor: 4.944

7.  Study on TRPV1-mediated mechanism for the hypersecretion of mucus in respiratory inflammation.

Authors:  J Yang; H M Yu; X D Zhou; V P Kolosov; J M Perelman
Journal:  Mol Immunol       Date:  2012-08-30       Impact factor: 4.407

Review 8.  Expression and physiological roles of TRP channels in smooth muscle cells.

Authors:  Christelle Guibert; Thomas Ducret; Jean-Pierre Savineau
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

9.  Stiffness changes in cultured airway smooth muscle cells.

Authors:  Steven S An; Rachel E Laudadio; Jean Lai; Rick A Rogers; Jeffrey J Fredberg
Journal:  Am J Physiol Cell Physiol       Date:  2002-09       Impact factor: 4.249

10.  Dynamics of matrix-free Ca2+ in cardiac mitochondria: two components of Ca2+ uptake and role of phosphate buffering.

Authors:  An-Chi Wei; Ting Liu; Raimond L Winslow; Brian O'Rourke
Journal:  J Gen Physiol       Date:  2012-06       Impact factor: 4.086

View more
  5 in total

Review 1.  Emerging concepts in smooth muscle contributions to airway structure and function: implications for health and disease.

Authors:  Y S Prakash
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-10-14       Impact factor: 5.464

2.  TRPV1 Blocking Alleviates Airway Inflammation and Remodeling in a Chronic Asthma Murine Model.

Authors:  Joon Young Choi; Hwa Young Lee; Jung Hur; Kyung Hoon Kim; Ji Young Kang; Chin Kook Rhee; Sook Young Lee
Journal:  Allergy Asthma Immunol Res       Date:  2018-05       Impact factor: 5.764

Review 3.  Crosstalk Between Signaling Pathways Involved in the Regulation of Airway Smooth Muscle Cell Hyperplasia.

Authors:  Hui Min Yap; Daud Ahmad Israf; Hanis Hazeera Harith; Chau Ling Tham; Mohd Roslan Sulaiman
Journal:  Front Pharmacol       Date:  2019-10-09       Impact factor: 5.810

Review 4.  Transient receptor potential ion-channel subfamily V member 4: a potential target for cancer treatment.

Authors:  Suyun Yu; Shuai Huang; Yushi Ding; Wei Wang; Aiyun Wang; Yin Lu
Journal:  Cell Death Dis       Date:  2019-06-24       Impact factor: 8.469

5.  Polymodal Transient Receptor Potential Vanilloid (TRPV) Ion Channels in Chondrogenic Cells.

Authors:  Csilla Szűcs Somogyi; Csaba Matta; Zsofia Foldvari; Tamás Juhász; Éva Katona; Ádám Roland Takács; Tibor Hajdú; Nóra Dobrosi; Pál Gergely; Róza Zákány
Journal:  Int J Mol Sci       Date:  2015-08-07       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.